Anaplastic Lymphoma Kinase (ALK)
1 clinical trials · Condition
◉ Watch Anaplastic Lymphoma Kinase (ALK)
| Record | Firm | Date |
|---|---|---|
| Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer (NCT01772797) | Novartis Pharmaceuticals | 2013-06-01 |
Track Anaplastic Lymphoma Kinase (ALK) automatically
Every clearance here is in the API, with alerts when new ones post.